Search

Displaying results 7391 - 7400 of 10000 in total
  1. Drug

    Sovaprevir

    go.drugbank.com/drugs/DB12069
    Investigational

    Sovaprevir has been investigated for the treatment of Hepatitis C, Chronic.

  2. Drug

    Vanutide cridificar

    go.drugbank.com/drugs/DB12132
    Investigational

    Vanutide cridificar has been investigated for the treatment of Alzheimer Disease.

  3. Drug

    BIIB021

    go.drugbank.com/drugs/DB12359
    Investigational

    BIIB021 has been investigated for the treatment of Tumors and Lymphoma.

  4. Drug

    Belotecan

    go.drugbank.com/drugs/DB12459
    Investigational

    Belotecan has been investigated for the treatment of Epithelial Ovarian Cancer.

    Categories: Topoisomerase I Inhibitors
  5. Drug

    Biphenyl dimethyl dicarboxylate

    go.drugbank.com/drugs/DB12475
    Investigational

    Nissel has been investigated for the treatment of Chronic Liver Disease.

  6. Drug

    PF-00446687

    go.drugbank.com/drugs/DB12517
    Investigational

    PF-00446687 has been investigated for the treatment of Erectile Dysfunction.

  7. Drug

    Combretastatin

    go.drugbank.com/drugs/DB12596
    Investigational

    Combretastatin has been investigated for the treatment of Anaplastic Thyroid Cancer.

  8. Drug

    ENTR-601-44

    go.drugbank.com/drugs/DB17836
    Investigational

    ENTR-601-44 is an exon 44 skipping phosphorodiamidate morpholino oligonucleotide (PMO). Developed by Entrada Therapeutics, it was investigated for the treatment of Duchenne muscular dystrophy.[L46641]

  9. Drug

    Danicamtiv

    go.drugbank.com/drugs/DB18962
    Investigational

    Danicamtiv is under investigation in clinical trial NCT04572893 (Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants or Other Causalities).

    Synonyms: 1-piperidinecarboxamide, 4-((1r)-1-((3-(difluoromethyl)-1-methyl-1h-pyrazol-4-yl)sulfonyl)-1-fluoroethyl)-n-3-isoxazolyl-, 4-((1r)-1-((3-(difluoromethyl)-1-methyl-1h-pyrazol-4-yl)sulfonyl)-1-fluoroethyl)-n-(1,2-oxazol-3-yl)piperidine-1-carboxamide
  10. Drug

    MBP134

    go.drugbank.com/drugs/DB18686
    Experimental

    MBP134 is a pan-ebolavirus cocktail comprising two broadly neutralizing human antibodies. It is under investigation for the treatment of Sudan ebolavirus (SUDV).